根据最新的财务报表(Form-10K),The Foschini Group Limited 的总资产为 $0,净损失为 $0
XCRT 的关键财务比率是什么?
The Foschini Group Limited 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Xcelerate Inc 的收入按细分市场或地理位置如何划分?
The Foschini Group Limited 最大收入来源是 The Foschini Group Limited Africa Retail,在最近的收益报告中收入为 40,314,200,000。就地区而言, South Africa 是 The Foschini Group Limited 的主要市场,收入为 39,432,800,000。
Xcelerate Inc 是否盈利?
不,根据最新的财务报表,The Foschini Group Limited 的净损失为 $0
Xcelerate Inc 有负债吗?
不,The Foschini Group Limited 的负债为 0
Xcelerate Inc 的流通股有多少?
The Foschini Group Limited 的总流通股为 0
关键数据
前收盘价
$0.0185
开盘价
$0.0185
当日区间
$0.0185 - $0.0197
52周范围
$0.0061 - $0.0211
交易量
29.9K
平均成交量
122.4K
股息收益率
--
每股收益(TTM)
--
市值
$8.5M
什么是 XCRT?
Xcelerate, Inc. is a medical company, which engages in the provision of acquiring intellectual property technology for medical applications. The company is headquartered in Mauldin, South Carolina. The company went IPO on 2004-10-06. The firm is engaged in three separate but related businesses within the medical, health and wellness sectors. The firm is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.